2025 PACUPrep BCCCP Preparatory Course Intravenous Fluid Therapy and Resuscitation Foundational Principles and Pathophysiology of Intravenous Fluid Therapy
Foundational Principles of Intravenous Fluid Therapy

Foundational Principles and Pathophysiology of Intravenous Fluid Therapy

Objectives Icon A checkmark inside a circle, symbolizing achieved goals.

Learning Objective

Describe the epidemiology, compartmental physiology, and risk factors that govern intravenous fluid administration in critically ill patients.

I. Epidemiology and Clinical Impact

Intravenous fluid administration is nearly universal in adult ICUs worldwide. Early resuscitation volumes, fluid composition, and cumulative balance are all linked to organ function and patient outcomes.

  • Over 90% of ventilated or vasopressor-dependent ICU patients receive ≥2–3 L of crystalloids within the first 24 hours.
  • Annual global usage reaches millions of liters, driving morbidity, resource utilization, and cost.
  • Balanced crystalloids reduce major adverse kidney events at 30 days (MAKE30) compared to 0.9% saline (14.3% vs. 15.4%).
  • Each additional liter of fluid infused in trauma correlates with a 5% increase in in-hospital morbidity.
  • Restrictive versus liberal strategies in septic shock show no difference in 90-day mortality, underscoring the need for physiology-guided resuscitation.
MAKE30 Outcomes: Balanced Crystalloids vs. Saline A bar chart comparing the rate of Major Adverse Kidney Events at 30 Days (MAKE30) between patients receiving balanced crystalloids (14.3%) and those receiving 0.9% saline (15.4%). The balanced crystalloid bar is slightly shorter, indicating a better outcome. MAKE30: Balanced Crystalloids vs. 0.9% Saline 14.3% Balanced Crystalloids 15.4% 0.9% Saline 20% 10% 0%
Figure 1. Balanced crystalloids were associated with a statistically significant reduction in the composite outcome of death, new renal-replacement therapy, or persistent renal dysfunction (MAKE30) compared to 0.9% saline in critically ill adults.
Pearl IconA shield with an exclamation mark. Key Pearls +
  • Track cumulative fluid balance electronically to detect a positive balance 6 hours earlier than manual charting.
  • Fluid composition matters: avoid high chloride loads in patients at risk for acute kidney injury (AKI).

II. Physiology of Fluid Compartments and Shifts

Total body water (TBW) distribution and membrane forces determine where administered fluid goes. Inflammation and endothelial injury profoundly alter these dynamics.

  • TBW ≈60% of lean body mass: 40% is intracellular fluid (ICF); 20% is extracellular fluid (ECF), which is further divided into 5% intravascular and 15% interstitial space.
  • Osmosis: Water moves toward higher solute concentration. The tonicity (effective osmolarity) of a fluid governs whether it expands the ECF or shifts into the ICF.
  • Starling Forces: Capillary hydrostatic pressure pushes fluid out of vessels, while oncotic pressure (from proteins like albumin) pulls fluid back in. Glycocalyx degradation in sepsis flattens this gradient, promoting leaks.
  • Capillary Leak: In severe inflammation, 20–30% of an isotonic crystalloid bolus can extravasate into the interstitium within hours, leading to “third spacing” and edema.
Fluid Compartments and Capillary Leak A diagram showing total body water distribution into intracellular and extracellular spaces. A magnified view shows a healthy capillary with an intact glycocalyx retaining fluid, contrasted with a septic capillary where a damaged glycocalyx leads to fluid and albumin leaking into the interstitial space. Total Body Water (~60% Body Weight) ICF (40%) ECF (20%) Interstitial (15%) Intravascular (5%) Healthy Capillary Intact Glycocalyx Albumin Fluid Septic Capillary (Capillary Leak) Damaged Glycocalyx Extravasation
Figure 2. Fluid distribution across body compartments. In sepsis, damage to the endothelial glycocalyx layer of capillaries leads to increased permeability, allowing fluid and albumin to leak into the interstitial space, causing edema and reducing intravascular volume.
Pearl IconA shield with an exclamation mark. Key Pearls +
  • Point-of-care ultrasound (IVC collapsibility, lung B-lines) enhances real-time volume assessment at the bedside.
  • Colloids (like albumin) do not reliably restore intravascular volume when the glycocalyx is disrupted, as they will also leak into the interstitium.

III. Influence of Chronic Diseases on Fluid Handling

Heart, kidney, and liver dysfunction each alter fluid tolerance and distribution, necessitating tailored strategies.

  • Heart Failure: Elevated venous pressures blunt preload responsiveness, and diuretic resistance worsens congestion. Patients are highly susceptible to fluid overload.
  • Chronic Kidney Disease (CKD): Reduced glomerular filtration rate (GFR) limits the body’s ability to excrete sodium and water. Small fluid loads can precipitate volume overload and hypertension.
  • Cirrhosis/Hypoalbuminemia: Low oncotic pressure from decreased albumin production favors fluid shifts into the third space, causing ascites and peripheral edema.
  • Composite Comorbidities: Patients with multiple organ dysfunctions require lower net fluid targets and frequent reassessment using dynamic tests (e.g., stroke volume variation, passive leg raise).
Pearl IconA shield with an exclamation mark. Key Pearls +
  • In refractory heart failure, ultrafiltration removes fluid but carries higher complication rates than stepped diuretic therapy.
  • Avoid large crystalloid boluses in advanced cirrhosis without albumin support; monitor closely for signs of pulmonary edema.

IV. Social Determinants and Risk Stratification

Socioeconomic and literacy barriers can influence a patient’s presentation, the timing of resuscitation, and their long-term recovery from critical illness.

  • Lower-income patients may present later in the course of shock, often with higher lactate levels and more severe hypotension at ICU admission.
  • Poor health literacy can impair adherence to outpatient diuretic regimens, leading to decompensation and emergent ICU admission for fluid overload.
  • Early screening for social determinants of health (SDOH) and interprofessional interventions (e.g., transport vouchers, multilingual education) can help reduce readmission risk.
  • Integrating a social vulnerability index into protocols can help identify high-risk patients who may require targeted support.
Pearl IconA shield with an exclamation mark. Key Pearls +
  • Partner with social work and pharmacy early in the ICU stay to address barriers that could affect fluid management and post-discharge follow-up.
  • Balance the feasibility of universal SDOH screening with targeted approaches to avoid missing vulnerable patients.

V. Clinical Presentation and Early Risk Identification

Differentiating hypovolemia from fluid overload is a critical first step that guides initial resuscitation and helps avoid iatrogenic harm.

Comparison of Clinical Signs in Hypovolemia vs. Fluid Overload
Signs of Hypovolemia (Under-resuscitation) Signs of Fluid Overload (Over-resuscitation)
Tachycardia, Hypotension Peripheral or sacral edema
Delayed capillary refill (>3 sec) Pulmonary crackles on auscultation
Oliguria or anuria Elevated Jugular Venous Pressure (JVP)
Flattened neck veins Recent, rapid weight gain
Dry mucous membranes Impaired wound healing
Rising BUN/creatinine ratio, hemoconcentration Hyponatremia, low hematocrit (dilutional)

Early warning scores (e.g., NEWS, qSOFA) and triage algorithms help identify patients needing urgent fluid assessment. Laboratory clues such as a rising BUN/creatinine ratio, hemoconcentration, and elevated lactate suggest under-resuscitation, while hyponatremia or a low hematocrit may reflect dilution from fluid overload.

Pearl IconA shield with an exclamation mark. Key Pearls +
  • Always correlate physical exam findings with ultrasound and hemodynamic data before intervening with additional fluids.
  • Reassess volume status after each 500–1,000 mL bolus to avoid “fluid creep”—the insidious accumulation of fluid from multiple small infusions over time.

References

  1. Semler MW, Self WH, Wanderer JP, et al. Balanced crystalloids versus saline in critically ill adults. N Engl J Med. 2018;378(9):829-839.
  2. Kjær MB, Cihoric M, Rasmussen BS, et al. Long-term effects of fluid restriction in septic shock: post hoc analysis of the CLASSIC randomised trial. Intensive Care Med. 2023;49(7):820-830.
  3. Wrzosek A, Dąbrowska A, Jakóbik K, et al. Intravenous fluid volume correlates with outcomes in trauma patients: A single-center retrospective study. Front Med (Lausanne). 2022;9:1040098.
  4. Glassford NJ, Mårtensson J, Eastwood GM, et al. The complexities of intravenous fluid research: from physiology to clinical practice. Acute Crit Care. 2016;31(4):197-205.
  5. Achanti A, Szerlip HM. Acid-Base Disorders in the Critically Ill. Clin J Am Soc Nephrol. 2023;18(1):102-112.
  6. Reuter DA, Hecker A, Schmidt T. Fluids in the ICU: which is the right one? Nephrol Dial Transplant. 2023;38(7):1603-1612.
  7. Carnethon MR, Pu J, Howard G, et al. Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association. Circulation. 2017;136(21):e393-e423. [Note: Adapted for SDOH context]
  8. Liu VX, Lu Y, Carey KA, et al. Derivation and Validation of a Novel Electronic Health Record-Based Score for Risk of In-Hospital Handoffs to the ICU. Crit Care Med. 2019;47(11):1582-1590. [Note: Adapted for fluid resuscitation context]
  9. Wardi G, Leisman DE. The Role of Social Determinants of Health in Critical Care. Crit Care Med. 2023;51(2):269-272.
Previous Lesson
Back to Lesson
Next Topic